Company Profile
UroGen Pharma Stock Price, News & Analysis
- Ticker:
- URGN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, UroGen Pharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
35.15 USD (+0.46%)
Close
Last updated: June 23, 2026 at 00:00
1.71B USD
Market cap
Why the stock is moving
URGN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
UroGen Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, UroGen Pharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
UroGen Pharma follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, UroGen Pharma sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
UroGen Pharma to Present at Upcoming Investor Conferences
Source: UroGen Pharma
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of UroGen Pharma (URGN)?
UroGen Pharma (URGN) most recently closed at 35.15 USD, a +0.46% move versus the previous session.
What is the market cap of UroGen Pharma (URGN)?
UroGen Pharma currently has a market capitalization of 1.71B USD on BioPharmSignal.
What does UroGen Pharma do?
UroGen Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is URGN stock listed?
UroGen Pharma (URGN) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, UroGen Pharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is UroGen?
UroGen Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is UroGen Pharma targeting with UroGen?
UroGen Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharma?
UroGen Pharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.